Human Immunodeficiency Virus Infections in the Middle East and North Africa: Prevalence, Risk, Prevention and Challenges
Journal Title: International Journal of Virology and AIDS - Year 2016, Vol 3, Issue 2
Abstract
Introduction/Objective: The Middle East and North Africa (MENA) has few recorded outputs regarding the prevalence of the human immunodeficiency viral (HIV) infections associated with acquired immune deficiency syndrome (AIDS). When we went through the HIV/AIDS in MENA, we found a hole in the scientific publications. Attention towards this issue progressed recently though, with few pre-clinical studies conducted. In the current review, we collected comprehensive data of HIV epidemiology in MENA and discussed the main challenges facing clinicians in charge with ailments in MENA and recommended some prevention strategies. The antiretroviral therapy (ART) has been present globally, thus delaying the world enterprise of providing new therapeutics and preventative candidates, even in rich nations such as Saudi Arabia. Methods: This review article following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and covering the most of MENA countries. PubMed, Embase, regional and international databases, as well as country-level reports were searched up to 2016. Primary studies reporting the prevalence/incidence of HIV, the prevalence of injecting or sexual risk behaviors, the proportion of risks in MENA, were eligible for inclusion. The quantity and geographic coverage of the data were assessed at country level. Prevention and challenges were also reported. Results and conclusion: Recently, numerous MENA countries did a remarkable effort to scale-up their awareness to this rising epidemic by developing tactics to tackle HIV and establishing national health-care programs. The scaling-up and developing of ART is very important in MENA. However, MENA has the lowest ART attention in the world, and the implementation of the WHO guidelines is likely to generate an even greater gap between those eligible for treatment and those receiving it, owing to either lack of medical awareness or adequate insurance, as well as cultural and social barriers. These issues stand as solid obstacles to effectively apply the HIV prevention system in MENA. Few countries in MENA have already established efficient programs to tackle HIV transmission from mothers to their kids, by frequent testing and care.
Survival among Dually Infected HIV Patients Compared to HIV-1 Mono-Infected Patients Receiving ART in Senegal: A Twelve-Year Cohort Study
In West Africa, HIV-2 single infection (HIV-2s) and HIV-1 + HIV-2 dual infection (HIV-D) remain endemic but their morbidity is progressively decreasing. Among HIV-D infected patients receiving antiretroviral therapy (ART...
Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1 DNA
Background Correct measurements of residual viremia and reservoir size are crucial in HIV-1 eradication trials and there is a need for sensitive and automated assays. The increasing worldwide diversity of HIV-1 subtypes...
The AIDS Myth at 30
In 1985 the KGB and East Berlin's professor of Biology started the AIDS disinformation campaign by accusing the United States of America of having constructed and spread the AIDS agent in the course of biological weapons...
Organotropic Kinetics in Acute Sublethal Transient Cytomegalovirus Infection in Mice
We determined the primary level of dissemination of the cytomegalovirus into the mouse organs and its significance. This was completed before we engaged in a wider project on the immune and molecular aspects of the patho...
Acute Pulmonary Embolism in Dual Dengue Fever and Influenza B Infection
Acute Pulmonary Embolism (PE) is a life-threatening condition and the common cause of death is due to obstruction of main pulmonary vessels by the embolus, resulting in pulmonary hypertension followed by right-sided hear...